1280823 |
Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. |
1281790 |
Molecular cloning of a novel protein-tyrosine phosphatase SH-PTP3 with sequence similarity to the src-homology region 2. |
7681217 |
Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. |
7681589 |
A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. |
7691811 |
Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. |
8041791 |
Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras. |
8216283 |
Cloning, expression and mutational analysis of SH-PTP2, human protein-tyrosine phosphatase. |
8810330 |
Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule. |
9062191 |
A family of proteins that inhibit signalling through tyrosine kinase receptors. |
9491886 |
Crystal structure of the tyrosine phosphatase SHP-2. |
9600074 |
Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2. |
10068651 |
Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. |
10209036 |
SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T-cell activation. |
10655584 |
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. |
10681522 |
Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs. |
11162587 |
Molecular cloning and characterization of SPAP1, an inhibitory receptor. |
11389028 |
Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. |
11414741 |
Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family. |
11433379 |
Structural and functional dissection of the cytoplasmic domain of the transmembrane adaptor protein SIT (SHP2-interacting transmembrane adaptor protein). |
11704759 |
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. |
11992261 |
PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. |
12058348 |
Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. |
12161469 |
PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome. |
12325025 |
PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13. |
12529711 |
PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning. |
12634870 |
Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. |
12717436 |
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. |
12739139 |
Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report. |
12960218 |
Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. |
12972546 |
Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells. |
14597715 |
The inhibitory potential of Fc receptor homolog 4 on memory B cells. |
14702039 |
Complete sequencing and characterization of 21,243 full-length human cDNAs. |
14961557 |
A novel PTPN11 mutation in LEOPARD syndrome. |
15102829 |
Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress. |
15121796 |
Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. |
15384080 |
Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation. |
15389709 |
Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome. |
15489334 |
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
15520399 |
PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. |
15526160 |
Signal transduction via the stem cell factor receptor/c-Kit. |
15592455 |
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. |
15690106 |
Genetic heterogeneity in LEOPARD syndrome: two families with no mutations in PTPN11. |
15889278 |
A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy. |
15948193 |
Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient. |
16679933 |
Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive). |
16733669 |
PTPN11 gene mutations: linking the Gln510Glu mutation to the 'LEOPARD syndrome phenotype'. |
16885344 |
ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. |
16956752 |
ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells. |
17213291 |
FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection. |
18559669 |
Regulation of RhoA-dependent ROCKII activation by Shp2. |
18604210 |
An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells. |
18829466 |
Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase. |
19020799 |
PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome. |
19167335 |
Large-scale structural analysis of the classical human protein tyrosine phosphatome. |
19342684 |
A novel and critical role for tyrosine 663 in platelet endothelial cell adhesion molecule-1 trafficking and transendothelial migration. |
19413330 |
Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. |
19509291 |
GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling. |
19690332 |
Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. |
19843936 |
FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. |
20068231 |
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. |
20170098 |
Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). |
20494825 |
Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration. |
20577567 |
Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. |
21269460 |
Initial characterization of the human central proteome. |
23112346 |
Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function. |
23186163 |
Toward a comprehensive characterization of a human cancer cell phosphoproteome. |
24275569 |
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. |
24891296 |
A PTPN11 allele encoding a catalytically impaired SHP2 protein in a patient with a Noonan syndrome phenotype. |
26742426 |
Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling. |
28074573 |
Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome. |